Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca)

J D Engel1, S D Kundu, T Yang

  • 1Department of Urology, Northwestern University Medical School, Chicago, Illinois 60611, USA.

Urology
|July 22, 1999
PubMed
Abstract

Insights

Restoring transforming growth factor-beta (TGF-beta) type II receptor (TbetaR-II) expression in aggressive Renca cells reduced tumor growth and weight. This demonstrates TbetaR-II’s role as a tumor suppressor gene in renal carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • The transforming growth factor-beta (TGF-beta) type II receptor (TbetaR-II) is crucial for TGF-beta signaling.
  • TbetaR-II is ubiquitously expressed in benign epithelial cells but often lost in aggressive cancers.
  • Renca, a murine renal carcinoma cell line, lacks TbetaR-II expression and exhibits high tumorigenicity.

Purpose of the Study:

  • To investigate the role of TbetaR-II as a tumor suppressor gene.
  • To determine if restoring TbetaR-II expression in Renca cells can decrease their tumorigenicity.
  • To elucidate the mechanism by which TbetaR-II influences renal carcinoma aggressiveness.

Main Methods:

  • Stable transfection of Renca cells with a retroviral TbetaR-II expression vector.
  • In vitro assessment of TGF-beta sensitivity using a 3H-thymidine incorporation assay.
  • In vivo evaluation of tumorigenicity in nude mouse xenograft models, comparing TbetaR-II transfected cells with wild-type and control vector cells.

Main Results:

  • TbetaR-II mRNA expression was successfully restored in Renca cells post-transfection.
  • Restored TbetaR-II expression re-sensitized cells to TGF-beta's growth inhibitory effects, which was reversible with a neutralizing antibody.
  • Xenografts from TbetaR-II transfected cells showed significantly reduced size, weight, and delayed tumor development compared to controls.

Conclusions:

  • TbetaR-II acts as a central mediator in controlling tumorigenicity in Renca cells.
  • Loss of TbetaR-II expression contributes to the aggressive phenotype of renal carcinoma.
  • Restoration of TbetaR-II function holds potential for therapeutic strategies targeting renal cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...